Pfizer COVID Shots Linked to 40% Higher All-Cause Mortality Compared to Moderna

November 10th, 2026

One more for your herniating Coincidence? file folder.

Via: Focal Points:

A major new peer-reviewed study conducted by MIT Professor Retsef Levi, Florida Surgeon General Dr. Joseph Ladapo, and researchers at the Florida Department of Health, followed nearly 2 million adults for 12 months, comparing mortality outcomes among recipients of Pfizer’s BNT162b2 and Moderna’s mRNA-1273 COVID-19 vaccines.

They identified striking differences across four mortality categories.

PFIZER RECIPIENTS HAD HIGHER MORTALITY THAN MODERNA RECIPIENTS:

ALL-CAUSE MORTALITY: 40% higher

CARDIOVASCULAR MORTALITY: 57% higher

COVID-19 MORTALITY: 91% higher

NON-COVID-19 MORTALITY: 37% higher

…

Applying the study’s 40% higher all-cause mortality hazard to an assumed 150 million U.S. Pfizer recipients and a baseline annual mortality rate of 0.87% produces the following calculation:

150,000,000 × 0.0087 × 0.40 = 522,000

This yields a hypothetical extrapolation of 522,000 excess deaths from Pfizer alone.

A more conservative extrapolation uses the study’s directly observed absolute mortality difference of 221 additional deaths per 100,000 Pfizer recipients compared with Moderna:

150,000,000 × (221 ÷ 100,000) = 331,500

This produces an alternative estimate of 331,500 additional deaths relative to Moderna if the mortality difference observed in Florida were applied nationwide.

Paper: Twelve-month all-cause mortality after initial COVID-19 vaccination with Pfizer-BioNTech or mRNA-1273 among adults living in Florida: Statewide cohort study

Leave a Reply

You must be logged in to post a comment.